Reports Home

Donald Abrams, MD

Gregory T. Carter, MD

Jay R. Cavanaugh, Ph.D.

Chris Conrad

Valerie and Mike Corral

Molly Fry, MD

Lester Grinspoon, MD

Rob Killian, MD

Steve Kubby

Phillip Leveque, MD

Martin Martinez

Raphael Mechoulam, PhD

Ian D. Meng, PhD

Tod H. Mikuriya, MD

Richard E. Musty, PhD

NORML Conference, 2006

William Notcott, M.D.

Francis Podrebarac, MD

Robert and Angel Raich

Bill S. Rosen MD

Ed Rosenthal

Ethan Russo, MD

CannabisMD.org

Gregory T. Carter, M.D.

Marijuana In The Management of Amyotrophic Lateral Sclerosis

Gregory Carter, M.D.
Bill S. Rosen M.D.

Abstract:

Marijuana has been proposed as treatment for a widening spectrum of medical conditions. Marijuana is a substance with many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). These include analgesia, muscle relaxation, bronchodilation, saliva reduction, appetite stimulation, and sleep induction. In addition, marijuana has now been shown to have strong antioxidative and neuroprotective effects, which may prolong neuronal cell survival. In areas where it is legal to do so, marijuana should be considered in the pharmacological management of ALS. Further investigation into the usefulness of marijuana in this setting is warranted.